Here’s the gist of the article: Private Equity firms are buying into the US healthcare space because they see it ripe with opportunities to cut cost and increase efficiency but it’s often resulted in worse access and quality of care. Also, they want to cut out practices without high margins, so getting rid of general practice firms and increasing Botox. The article also talked about private equity firms buying into hospice care as well.